Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Times Interest Earned (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Times Interest Earned readings, the most recent being -$4.06 for Q1 2026.

  • On a quarterly basis, Times Interest Earned fell 110.64% to -$4.06 in Q1 2026 year-over-year; TTM through Mar 2026 was -$9.79, a 227.57% decrease, with the full-year FY2025 number at $1.81, up 110.02% from a year prior.
  • Times Interest Earned hit -$4.06 in Q1 2026 for Atara Biotherapeutics, up from -$35.3 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $38.15 in Q1 2025 to a low of -$22055.0 in Q1 2022.
  • Median Times Interest Earned over the past 5 years was -$35.3 (2025), compared with a mean of -$1407.1.
  • The widest YoY moves for Times Interest Earned: up 240.78% in 2025, down 194.15% in 2025.
  • Atara Biotherapeutics' Times Interest Earned stood at -$645.63 in 2022, then surged by 92.1% to -$50.99 in 2023, then surged by 76.47% to -$12.0 in 2024, then crashed by 194.15% to -$35.3 in 2025, then soared by 88.5% to -$4.06 in 2026.
  • The last three reported values for Times Interest Earned were -$4.06 (Q1 2026), -$35.3 (Q4 2025), and -$3.93 (Q3 2025) per Business Quant data.